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Introduction
Twenty five years ago in the Journal of Cell Biology, Professor 
Yoshinori Ohsumi and colleagues published the first of several 
landmark papers demonstrating molecular control of macroau-
tophagy in response to nutrient starvation in Saccharomyces 
cerevisiae (Takeshige et al., 1992). Thereafter, several groups 
identified autophagy-related proteins (ATGs), evolutionarily 
conserved molecules that control fundamental aspects of the 
macroautophagy pathway, including the formation of autopha-
gosomes, double membrane vesicles that capture cellular cargo 
and subsequently deliver them to the lysosome for degradation 
(Tsukada and Ohsumi, 1993; Thumm et al., 1994; Harding et al., 
1996). Since the discovery of ATGs, an explosion of research on 
autophagy has led to seminal advances in understanding the mo-
lecular regulation of the autophagy trafficking process, dissect-
ing how autophagy controls cell survival and metabolic fitness 
in response to countless stressors, and illuminating the diverse 
functions of the autophagy pathway in both normal physiology 
and disease (Choi et al., 2013; Kaur and Debnath, 2015). At 
the same time, we have begun to appreciate that various ATGs 
and other autophagy regulators are deployed in assorted funda-
mental processes that are distinct and separable from their well- 
established roles in mediating autodigestion via the lysosome. 
This review highlights this exciting new facet of autophagy 
research and summarizes our current understanding of these 
autophagy-related functions and signaling pathways mediated 
by individual ATGs as well as entire cell biological subroutines 
using multiple components of the autophagy machinery.
Classic autophagy versus autophagy-
related pathways
Autophagy consists of three cellular self-eating mechanisms 
that converge on the lysosome: microautophagy, chaperone- 
mediated autophagy, and macroautophagy. Among these, mac-
roautophagy (hereafter called autophagy) is the most well 
studied and genetically controlled by ATGs. Classic autophagy 
proceeds through multiple “canonical” steps that include (1) 
initiation by an autophagy-inducing signal, (2) nucleation of 
an isolation membrane or phagophore assembly site, (3) elon-
gation and sealing of this double membrane around the cargo 
to be sequestered to form an autophagosome, (4) docking and 
fusion of the autophagosome with the lysosome to form an au-
tolysosome, and (5) degradation of the vesicle contents by lyso-
somal enzymes (Fig. 1 A). Initiation, nucleation, and elongation 
require the hierarchical recruitment and activity of ∼15 ATGs 
and other proteins to the phagophore assembly site to construct 
the autophagosome (Codogno et al., 2011; Mizushima et al., 
2011). In this context, the term “noncanonical autophagy” 
refers to the formation of classic double membrane autopha-
gosomes that does not require the activity of one or more key 
ATGs. Nonetheless, both canonical and noncanonical autoph-
agy are fundamentally autodigestive pathways requiring auto-
phagosome formation, followed by fusion with the lysosome 
(Codogno et al., 2011).
Adding to this complexity, ATG proteins, both individu-
ally and as part of larger networks, control pathways that either 
do not involve the formation of a classic autophagosome or do 
not terminate in lysosomal degradation and nutrient recycling 
(Subramani and Malhotra, 2013). Although not inclusive, the 
list of autophagy-related processes includes secretion and exo-
cytosis, LC3-associated phagocytosis (LAP), viral replication 
The identification of conserved autophagy-related pro-
teins (ATGs) that mediate bulk degradation of cytosolic 
material laid the foundation for breakthroughs linking 
autophagy to a litany of physiological processes and dis-
ease conditions. Recent discoveries are revealing that 
these same ATGs orchestrate processes that are related 
to, and yet clearly distinct from, classic autophagy. 
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signaling cascades. Here, we define common processes 
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ways. Elucidating the molecular events that distinguish 
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understanding of the origin of diseases ranging from 
autoimmunity to cancer.
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and exit, antigen presentation, and ATG-mediated regulation of 
inflammatory and immune signaling. Importantly, these pro-
cesses are fundamentally distinct from classic autophagy, and 
certainly, many can be construed as “noncanonical” functions 
for the individual ATG proteins that are involved. However, they 
are not by definition “noncanonical autophagy” in its strictest 
sense. Hence, to avoid confusion, the term “noncanonical” 
should be avoided when referring to these autophagy-related 
processes. In the following sections, we overview our current 
understanding of this diverse collection of autophagy-related 
processes that are distinct from classic autophagy.
Secretory autophagy
In addition to its established role in lysosomal degradation, 
the autophagy machinery controls extracellular secretion. 
Evidence to date most notably implicates ATGs in unconven-
tional secretion of proteins lacking an N-terminal signal se-
quence (Dupont et al., 2011; Deretic et al., 2012; Malhotra, 
2013; Subramani and Malhotra, 2013). Whereas the majority 
of eukaryotic secretory proteins classically transit to the sur-
face via the ER and Golgi apparatus, a growing list of proteins 
traffic through unconventional mechanisms that do not require 
insertion into the ER and/or bypass the Golgi (Rabouille et al., 
2012; Malhotra, 2013). In addition, some classically secreted 
proteins appear to be preferentially rerouted through uncon-
ventional pathways to facilitate trafficking during stress (Gee 
et al., 2011). Studies to date have uncovered clear genetic re-
quirements for two proteins originally implicated in the stack-
ing of the Golgi apparatus, GRA SP55 and GRA SP65, as well 
as ATGs in mediating these alternative secretory pathways 
(Rabouille et al., 2012; Malhotra, 2013; Zhang and Schekman, 
2013). ATGs have been genetically linked to the unconventional 
secretion of acyl-CoA-binding protein Acb1 in yeast (AcbA in 
Dictyostelium discoideum; Duran et al., 2010; Manjithaya et 
al., 2010), several inflammatory mediators in mammalian cells, 
including IL-1β and IL-18; the high mobility group protein B1 
(HMGB1); and finally, the plasma membrane trafficking of the 
integral membrane protein ΔF508 CFTR (Dupont et al., 2011; 
Figure 1. Classic autophagy compared with related trafficking pathways. (A) Classic autophagy: Diverse stimuli elicit the hierarchical recruitment and 
activity of multiple ATGs (yellow) and other regulatory proteins (blue) to construct the double membrane autophagosome. The lipidation of LC3 (LC3-II) is 
crucial for the capture of autophagic cargo and to stabilize of the inner autophagosomal membrane. The autophagosome subsequently fuses with the lyso-
some in a STX17-dependent manner, resulting in degradation of the vesicle contents by lysosomal enzymes. (B) Secretory autophagy: ATGs mediate the un-
conventional secretion of multiple proteins (e.g., Acb1 in yeast, and IL-1β, IL-18, and HMGB1 in mammalian cells) that lack an N-terminal signal sequence. 
These targets are postulated to be released via several putative mechanisms. First, the ATG conjugation machinery promotes the formation of an LC3+ auto-
phagosome-like intermediate, and the contents enwrapped within the inner membrane of autophagosome are released extracellularly instead of degraded 
in lysosomes. Second, targets of secretory autophagy, such as IL-1β, are translocated into the intramembrane space of an LC3+ double membrane vesicular 
intermediate that fuses directly with the plasma membrane or fuses with a MVB intermediate that is secreted. Last, although formal experimental evidence 
is lacking, secretory autophagy may involve an MVB/amphisome intermediate and the exocytic release of small extracellular microvesicles. Regardless of 
the exact pathway, recent work indicates that secretory autophagy proceeds through a dedicated SNA RE machinery, which diverts secreted targets away 
from the lysosome and toward the plasma membrane (PM). (C) LAP: the phagocytosis of pathogens and other prey in certain cell types (e.g., macrophages 
and dendritic cells) recruits UVR AG and Rubicon (RUB CN), thereby activating the Beclin-1–VPS34 complex to generate phosphatidylinositol 3-phosphate 
and NOX2, an NAD PH oxidase that generates ROS inside the phagosome. This subsequently triggers the recruitment and activation of the ATG conjugation 
machinery, which mediates LC3-II at the single membrane phagosome. LC3-II expedites fusion to lysosomes and degradation of the offending pathogen.
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Gee et al., 2011). To date, apart from these limited targets, the 
broader autophagy-dependent secretome remains uncharacter-
ized. Accordingly, recent quantitative proteomic analysis of the 
secretome from ATG5-deficient macrophages has uncovered 
new leaderless proteins that may be secreted in an autophagy- 
dependent manner (Kimura et al., 2017). However, it remains 
unclear from these genetic loss-of-function studies whether the 
observed secretory defects represent a direct versus indirect 
consequence of impaired autophagy.
The mechanistic underpinnings of secretory autophagy 
are only beginning to emerge, and numerous questions remain 
unaddressed. First, despite the genetic interconnections be-
tween ATGs and Grh1, the yeast GRA SP orthologue, in S. cer-
evisiae, recent work questions whether autophagy and Grh1 
truly converge on a common secretory pathway (Cruz-Garcia et 
al., 2014). Second, although ATGs that promote early autopha-
gosome formation are genetically required for unconventional 
secretion, it is unclear whether secretory autophagy targets are 
actually captured into the autophagosomal lumen (Fig.  1  B). 
In fact, recent work demonstrates that IL-1β secretion requires 
ATGs but proceeds via translocation into the intermembrane 
space of the autophagosome (Zhang et al., 2015; Fig.  1  B). 
Third, it remains unclear how secreted targets are transported to 
the cell surface. Because evidence supports that contents of mul-
tivesicular bodies (MVBs) can be directly exported to the cell 
surface, most notably the release of small extracellular microve-
sicles (exosomes), a role for the late endocytic pathway seems 
attractive (Colombo et al., 2014; Fig. 1 B). At the same time, 
recent evidence demonstrates interconnections between autoph-
agy and the retromer complex, a protein assembly implicated in 
plasma membrane exocytosis of diverse molecules from early 
endosomes (Steinberg et al., 2013). During metabolic stress, the 
induction of autophagy elicits LC3+ autophagic compartments 
that bind and sequester a key inhibitor of retromer complex, the 
RabGAP protein TBC1D5; as a result, autophagy activates the 
retromer-driven translocation of proteins to the plasma mem-
brane surface, most notably the glucose transporter GLUT1/
SLC2A1 (Roy et al., 2017). Last, defining the mechanisms by 
which targets of secretory autophagy are diverted away from ly-
sosomal degradation remains an important question for further 
study. Indeed, recent work indicates that secretory autophagy 
involves autophagosome-like vesicles that bypass STX17- 
dependent fusion with lysosomes; rather, they use the SNA RE 
protein SEC22B in combination with plasma membrane syn-
taxins to complete cargo secretion (Kimura et al., 2017; Fig. 1).
In addition to unconventional secretion, ATGs promotes 
the efficient egress of secretory lysosomes in osteoclasts (De-
Selm et al., 2011) and the conventional secretion of cytokines 
during oncogene-driven cancer cell invasion and senescence 
(Narita et al., 2011; Lock et al., 2014). Further dissecting the 
cellular mechanisms through which autophagy mediators fa-
cilitate these diverse secretory processes remains an important 
topic for future study.
LAP
Studies of LAP poignantly illustrate how key elements of 
the core autophagy machinery can be redirected toward lyso-
somal pathways that are distinct from the canonical autopha-
gosome-to-lysosome cascade. LAP represents a process akin 
to macroautophagy in which phagosomes engulf extracellular 
contents, such as microorganisms or dying cells, which are 
subsequently trafficked to the lysosome (Sanjuan et al., 2007). 
During LAP, elements of the autophagy machinery are recruited 
to phagosomes, upon which they facilitate maturation and the 
digestion of phagosomal contents (Fig.  1  C). Originally dis-
covered during phagocytosis of particles containing Toll-like 
receptor (TLR) ligands, LAP involves the recruitment of the 
Beclin-1 (BECN1)–VPS34 complex to the phagosome, re-
sulting in production of phosphatidylinositol 3-phosphate and 
the subsequent formation of phosphatidylethanolamine lipi-
dated, membrane-bound LC3 (LC3-II; (Sanjuan et al., 2007). 
LC3-II facilitates phagosome maturation in LAP, probably 
by recruiting molecules that enhances fusion to the endolyso-
somal compartment, such as the homotypic fusion and protein 
sorting complex involved in Rab7-mediated lysosomal fu-
sion (McEwan et al., 2015).
In addition to Beclin-1, multiple ATGs are required for 
LAP, including all key elements of the LC3 conjugation ma-
chinery (ATG3, ATG5, ATG7, ATG12, and ATG16L; Marti-
nez et al., 2011). Despite this common utilization of multiple 
ATGs, LAP is a mechanistically distinct process. During classic 
autophagy, LC3 lipidation occurs on early double membrane 
structures, called phagophores, and functions in the capture 
of autophagic cargo and to enhance the stability of the inner 
autophagosomal membrane (Stolz et al., 2014; Tsuboyama et 
al., 2016). In contrast, during LAP, components of the autoph-
agy conjugation machinery recruit LC3-II directly onto pha-
gosomes, which are single membrane organelles. As a result, 
LAP does not use the ULK (unc-51–like autophagy activating 
kinase) complex that initiates canonical autophagy (Martinez 
et al., 2011). Notably, similar pathways direct LC3 conjugation 
onto single-membrane organelles during entosis and macropi-
nocytosis, two processes that also converge on the lysosome 
(Florey et al., 2011). Furthermore, LAP uses a unique VPS34 
complex, composed of Beclin-1, UVR AG, and Rubicon (RUB 
CN), a protein that is inhibitory to classic autophagy (Martinez 
et al., 2015). Last, generation of reactive oxygen species (ROS) 
by NAD PH oxidase–2 (NOX2) has also been critically impli-
cated in the control of LAP (Martinez et al., 2015).
LAP serves as a host defense system targeting several 
pathogens, including Aspergillus fumigatus and Salmonella 
typhimurium (Huang et al., 2009; Martinez et al., 2015) and 
has emerged as a key regulator of inflammation and immunity. 
Previous studies have implicated autophagy in antigen presen-
tation to T cells by major histocompatibility complex (MHC) 
molecules (Dengjel et al., 2005; Schmid et al., 2007). However, 
optimal MHC-II presentation of peptides from phagocytosed 
pathogens requires LC3 targeting to phagosomes by ATGs and 
NOX2, suggesting that LAP mediates presentation of extra-
cellularly derived antigens (Romao et al., 2013). Importantly, 
LAP directs the production of type I IFN (IFN-I), namely 
IFN-α, in response to host-DNA containing immune complexes 
by plasmacytoid dendritic cells (Henault et al., 2012). In ad-
dition to controlling the immune response, LAP is required 
for the phagocytosis and degradation of photoreceptor outer 
segments by retinal pigment epithelial cells in mice, which is 
essential for proper vision (Kim et al., 2013). Overall, these 
studies reinforce the physiological importance of LAP as an au-
tophagy-related pathway.
ATGs in host–pathogen interactions
In addition to LAP, studies have uncovered a growing list of 
nonautophagic functions mediated by ATGs that modulate the 
infection of host cells and tissues. In this section, we focus 
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on how individual ATGs can either augment or diminish the 
propagation of assorted viruses as well as how ATGs restrict 
intracellular pathogens via pathways that are distinct from both 
classic autophagy and LAP.
Subversion during viral replication and trans-
mission. Growing evidence supports that viruses use LC3+ 
membranes to exit host cells via exocytic pathways analogous 
to secretory autophagy (Fig. 2). Infections by poliovirus and 
coxsackievirus B (CVB), two nonenveloped RNA viruses, re-
sult in the formation of LC3+ double membrane vesicles in an 
ATG-dependent manner, which serve as scaffolds for viral 
replication complexes (Jackson et al., 2005; Wong et al., 
2008). Instead of degradation in the lysosome, sequestered 
virions are released from cells within a membrane coat 
through a process termed autophagosome-mediated exit with-
out lysis (Fig. 2 A; Taylor et al., 2009). The “envelope” ac-
quired during egress shields virion clusters from immune 
recognition and aids entry into neighboring cells (Bird et al., 
2014; Chen et al., 2015b). Consistent with these studies that 
an autophagy-like process is required for viral replication and 
spread, ATG5 deletion in pancreatic acinar cells of mice leads 
to a 2,000-fold reduction in CVB replication and protection 
from pancreatitis (Alirezaei et al., 2012). In addition to these 
picornaviruses, lipidated LC3 also contributes to the envelop-
ment and exocytosis of certain herpesviruses during lytic in-
fection. Epstein-Barr virus and varicella-zoster virus acquire 
LC3-conjugated membranes during envelope acquisition in 
the cytosol, which can be detected in purified virions 
(Fig. 2 B; Nowag et al., 2014; Buckingham et al., 2016). Ac-
cordingly, inhibiting LC3 lipidation via ATG12 or ATG16L1 
knockdown impairs viral exit and results in the accumulation 
of viral DNA in the cytosol (Nowag et al., 2014). Finally, in-
fluenza A virus (IAV) encodes an ion channel protein, matrix 
protein 2, that blocks lysosomal degradation of the virion and 
facilitates viral egress through binding and redirecting LC3-II 
to the plasma membrane. Notably, although the improved fil-
amentous budding of IAV is dependent on ATG conjugation 
pathways that lipidate LC3, the overall infectious virus pro-
duction remains intact (Fig.  2  C; Gannagé et al., 2009; 
Beale et al., 2014).
In addition to these effects on viral exocytosis, interactions 
with LC3 are also required for the processing and inclusion of 
HIV Gag into the virion, whereas HIV Nef inhibits Beclin-1 
to prevent virion degradation through autophagy (Kyei et al., 
2009). In contrast, the multilamellar membranes that harbor 
coronavirus replication complexes are decorated with the non-
lipidated form of LC3; down-regulation of LC3 impairs viral 
replication, but ATG7 deletion has no effect (Reggiori et al., 
2010). Thus, viruses subvert LC3-mediated membrane traffick-
ing events through different ways.
Although we focus on strategies by which viruses coopt 
ATGs for their own benefit, some viruses are restricted by auto-
phagy. For example, autophagic degradation of ER, reticuloph-
agy, restricts dengue and Zika virus replication on ER-derived 
membranes. The NS3 protease encoded by these and other fla-
viviruses counteract this inhibition by cleaving the reticuloph-
agy receptor FAM134B (Lennemann and Coyne, 2017). Also, 
multiple herpesviruses encode proteins that bind and inhibit Be-
clin-1 to avoid autophagy-mediated targeting to the lysosome 
and antigen presentation to T cells (Deretic and Levine, 2009). 
In other situations, it may be nonautophagic functions of ATGs 
that determine virulence, as suggested by an siRNA screen 
comparing the requirement of diverse ATGs during infection 
by six viruses (Mauthe et al., 2016). This screen revealed that 
many of these proteins augment or diminish the replication of 
individual viruses independent of other ATGs, consistent with 
the conclusion that nonautophagic functions of ATGs are perva-
sive during viral infection.
When antimicrobial immunity is not xenophagy 
or LAP. Xenophagy, in which an internalized microbe is se-
questered in an autophagosome and targeted to the lysosome, is 
an established form of cell-autonomous defense (Cadwell, 
2016). However, mechanisms by which ATGs restrict intracel-
lular pathogens are sometimes radically different from classic 
autophagy or LAP. The cytokine IFN-γ inhibits Toxoplasma 
gondii replication in macrophages by triggering a process re-
ferred to as Targeting by AutophaGy proteins (TAG), which re-
quires ATGs involved in LC3 conjugation, but not the lysosome. 
Instead of promoting acidification, the ATG8 orthologue GAB 
ARA PL2 (GATE-16) recruits IFN-inducible GTPases to the 
Figure 2. LC3-conjugated membranes support viral exit. 
(A) Picornavirus (circles), such as poliovirus and CVB, pro-
mote the formation of LC3-II+ double membrane vesicles. LC3- 
conjugated membranes support viral replication as well as 
autophagosome-mediated exit without lysiss (AWOL), the exo-
cytic release of multiple virions within a LC3+ membrane-bound 
coat. (B) For certain enveloped viruses (hexagons), such as 
the herpesviruses Epstein-Barr virus (EBV) and varicella-zoster 
virus (VZV), LC3-coupled membranes are incorporated into 
the viral envelope and promote viral release during lytic infec-
tion. (C) During IAV (stars) infection, the viral product matrix 
protein 2 (M2, diamonds) interacts with lipidated LC3 (LC3-II) 
to block autophagosome-to-autolysosome maturation in the 
host cell as well as redirect LC3-II to the cell surface. The 
translocation of LC3-conjugated membranes to the plasma 
membrane is important for the filamentous budding of IAV 
and the stability of virions in the extracellular milieu.
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parasitophorous vacuole where they disrupt the membrane and 
destroy the replicative niche of T. gondii (Choi et al., 2014; Park 
et al., 2016b; Sasai et al., 2017). A similar mechanism disrupts 
the membranous structures on which noroviruses replicate (Bi-
ering et al., 2017). Additionally, though xenophagy inhibits 
Mycobacterium tuberculosis replication in cultured macro-
phages, experiments using cell type-specific knockout mice re-
vealed a surprising autophagy-independent function of ATG5 in 
neutrophils. Deletion of ATG5, but not the other ATGs involved 
in LC3 conjugation, increases the amount of neutrophils that 
infiltrate and damage the lung during Mycobacterium tubercu-
losis infection (Kimmey et al., 2015). As with viruses, bacteria 
can benefit from selective components of the autophagy ma-
chinery. The multimembrane vacuoles that support Brucella 
abortis replication are generated by ATGs that control PI3 ki-
nase activity (ULK1, Beclin-1, and ATG14), but not ATGs re-
quired for LC3 conjugation (ATG7, ATG16L1, ATG5, LC3B, 
and ATG4B) (Starr et al., 2012). In addition to these cell- 
autonomous functions of ATGs during infection, nonautophagic 
ATG functions are important for immune signaling pathways 
that contribute to multi-cellular immunity, which is discussed 
in the following section.
ATG-mediated inflammatory and 
immune signaling
ATGs have a fundamental role in suppressing immune signaling 
(Cadwell, 2016). Among the first indications that autophagy ex-
acts inhibitory functions came from population genetic studies 
implicating a coding variant of ATG16L1 in Crohn’s disease, a 
type of inflammatory bowel disease (IBD) associated with an 
abnormal immune response to the gut microbiota. Consistent 
with this genetic association, ATG16L1 deletion causes macro-
phages to overproduce the cytokine IL-1β, which mediates in-
testinal inflammation (Saitoh et al., 2008). Although increased 
production of immune effectors is pathological in this setting, 
Atg16L1 mutation unexpectedly enhances innate immune re-
sistance to oral infection by the Gram-negative bacterium Cit-
robacter rodentium (Marchiando et al., 2013). Additionally, 
deletion of other ATGs throughout the autophagy pathway leads 
to a general increase in cytokine levels that promote resistance 
to influenza virus infection (Lu et al., 2016) and inhibition of 
herpesvirus reactivation from latency (Park et al., 2016a). In 
this section, we provide examples highlighting different mech-
anisms by which ATGs reduce signaling downstream of cy-
tosolic pathogen sensors.
ATGs restrict retinoic acid–inducible gene I 
(RIG-I) antiviral signaling. The presence of nucleic acid in 
the cytoplasm derived from intracellular pathogens induces tran-
scription of IFN-I. The magnitude of this response is regulated 
by ATGs through both autophagy-dependent and -independent 
mechanisms. RIG-I binds short double-stranded RNA with a 
5′ppp moiety, which exposes the caspase activation and recruit-
ment domain (CARD) to allow interaction with the CARD of 
mitochondrial antiviral signaling protein (MAVS; Yoneyama et 
al., 2004; Kawai et al., 2005; Meylan et al., 2005; Seth et al., 
2005). After this CARD–CARD interaction, MAVS oligomeri-
zes on the mitochondrial outer surface to activate TBK-1, which 
in turn leads to the phosphorylation and nuclear translocation of 
the transcription factors IFN regulatory factor 3 (IRF3), IRF7, 
and NFκb (Honda et al., 2005; Seth et al., 2005). The ATG5–
ATG12 conjugate inhibits this RNA recognition pathway by 
binding the CARDs of RIG-I and MAVS (Fig. 3; Jounai et al., 
2007). Although it is unclear how these interactions prevent 
MAVS function, the direct binding of ATG5–ATG12 to CARDs 
suggests that the mechanism is autophagy-independent. An al-
ternative mechanism involves increased IFN-I production upon 
disruption of mitophagy. ROS from damaged mitochondria ac-
cumulate upon ATG5 deletion, which enhances RIG-I signaling 
(Fig. 3; Tal et al., 2009). Mitophagy also mediates the concurrent 
degradation of MAVS upon its translocation to mitochondria. 
The recruitment of the ATG16L1–ATG5–ATG12 complex to 
mitochondria by NLRX1 and elongation factor Tu (TUFM) de-
creases MAVS activity (Fig. 3; Lei et al., 2012). The importance 
of this pathway is highlighted by the observation that the human 
parainfluenza virus type 3 matrix protein induces mitophagy 
through interaction with TUFM, leading to decreased immune 
signaling and increased viral replication (Ding et al., 2017). 
Also, a single base substitution that confers the ability of the 
viral polymerase basic protein 2 to bind TUFM and induce auto-
phagy allows avian influenza virus to infect human cells (Kuo et 
al., 2017). Most likely through a similar process, the mitochon-
drial protein COX5B binds ATG5 and MAVS, and reduces ROS 
and IFN-I production during viral infection (Zhao et al., 2012). 
The commonality in these studies is that inhibiting the 
ATG5–ATG12 conjugate increases IFN-I and decreases rep-
lication of RNA viruses.
ATG control of innate immune DNA-sensing 
pathways. Cyclic GMP-AMP synthase (cGAS) generates the 
dinucleotide cyclic GMP-AMP (cGAMP) upon binding dou-
ble-stranded DNA in the cytosol (Sun et al., 2013; Wu et al., 
Figure 3. ATGs in inflammatory and immune signaling. ATGs regulate im-
mune signaling cascades through autophagy-dependent and -independent 
mechanisms. The mitochondrial protein TUFM recruits the ATG16L1–
ATG5–ATG12 complex to mediate the autophagic removal of mitochon-
dria that produce ROS, an activator of RIG-I signaling and the NLRP3 
inflammasome. By targeting mitochondria, autophagy further inhibits IFN-I 
production by removing the signaling intermediate MAVS, which aggre-
gates on mitochondrial surfaces downstream of viral RNA recognition by 
RIG-I. Also, the ATG5–ATG12 complex inhibits RIG-I and MAVS through 
an inhibitory binding event. Beclin-1 prevents sustained signaling by in-
ducing the autophagic removal of cytosolic DNA and inhibiting cGAS 
through direct binding. cGAMP generated by cGAS activates ULK1 to 
inhibit STI NG in a negative feedback loop. ATG9L1 interferes with the 
trafficking of STI NG to prevent continuous TBK-1 activation.
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2013). Similar to RNA sensing by RIG-I, STI NG (Stimulator of 
interferon genes) mediates a TBK-1 dependent signaling cas-
cade in the presence of cGAMP (Chen et al., 2016). Deletion of 
ATG9L1, but not other ATGs, increases the colocalization be-
tween STI NG and TBK-1 to enhance IFN-I production in re-
sponse to cytosolic DNA (Fig.  3; Saitoh et al., 2009). Also, 
generation of cGAMP by cGAS activates ULK1, which phos-
phorylates and inhibits STI NG while also inducing autophagy 
(Fig. 3; Konno et al., 2013). Similarly, Beclin-1 can bind and 
inhibit cGAS and simultaneously mediate the degradation of 
cytoplasmic DNA through autophagy (Fig.  3; Liang et al., 
2014). Thus, Beclin-1 prevents sustained cGAS activation 
through both direct inhibition and depriving the enzyme of its 
substrate. In these examples, conserved autophagy proteins 
(ATG9L1, ULK1, and Beclin-1) display functions independent 
of autophagy-related processes, although these functions do not 
necessarily preclude their role in classic autophagy.
ATGs and inflammasome activation. Inflam-
masomes are multiprotein complexes that induce the cleavage 
of pro–IL-1β and pro–IL-18 by caspase-1 to generate the acti-
vate forms of these cytokines (Sharma and Kanneganti, 2016). 
The NLRP3 inflammasome responds to a variety of stimuli that 
directly or indirectly cause the release of ROS and DNA from 
leaky mitochondria (e.g., bacterial toxins and microcrystalline 
substances). Inhibiting mitophagy, therefore, leads to accumu-
lation of damaged mitochondria that induce pathological cyto-
kine production downstream of NLRP3 inflammasome 
activation (Fig. 3; Saitoh et al., 2008; Zhong et al., 2016). ATGs 
also inhibit the caspase-11 inflammasome, which is activated by 
the bacterial cell wall component lipopolysaccharide in the cy-
tosol. When IFN-inducible GTPases attack the Salmonella- 
containing vacuole as part of the host defense mechanism, LC3 
is recruited to the damaged membrane by the linker protein 
NDP52 to mediate the autophagic sequestration of bacteria and 
lipopolysaccharide, which inhibits inflammasome activation 
(Meunier et al., 2014). Hence, it is likely that removal of dam-
aged vesicles and organelles (or their contents) through classic 
autophagy restrains inflammasome activity, thereby explaining 
why inhibiting autophagy proteins such as ATG16L1 enhance 
IL-1β and IL-18 production.
ATGs in inflammatory diseases
Here, we use IBD, rheumatoid arthritis (RA), and systemic 
lupus erythematosus (SLE) as examples of how ATGs contrib-
ute to complex inflammatory diseases. IBD includes Crohn’s 
disease and ulcerative colitis, and is frequently a debilitating 
condition that involves chronic inflammation in the small intes-
tine or colon, although any part of the gastrointestinal tract can 
be affected. Many genetic variants that increase risk of IBD, 
including several known to affect autophagy, are also found in 
individuals without disease (Lassen and Xavier, 2017). A par-
ticularly common polymorphism in ATG16L1 (up to 50% het-
erozygosity in certain populations) linked to Crohn’s disease 
introduces a caspase-3 cleavage site that destabilizes the protein 
product (ATG16L1T300A), thereby causing a reduction in auto-
phagy (Lassen et al., 2014; Murthy et al., 2014). ATG16L1T300A 
is associated with structural defects in Paneth cells, intestinal 
epithelial cells that produce antimicrobial granules (Cadwell et 
al., 2008). Additional inflammatory pathologies in the intestinal 
epithelium of Atg16L1 mutant mice is triggered by a commen-
sal enteric virus (Cadwell et al., 2010; Kernbauer et al., 2014), 
or by dual deletion of ATG16L1 and the ER stress transcription 
factor XBP-1 in Paneth cells (Adolph et al., 2013). These find-
ings are consistent with epidemiological observations suggest-
ing that IBD is caused by the confluence of multiple genetic and 
environmental susceptibility factors.
Several findings support the idea that the classic autophagy 
function of ATG16L1 is critical for protecting the epithelial bar-
rier and preventing a sustained immune reaction. ATG-deficient 
Paneth cells display unresolved ER stress and mitochondrial 
damage that contribute to necroptosis, a type of programmed 
necrotic cell death (Diamanti et al., 2017; Matsuzawa-Ishimoto 
et al., 2017; Tschurtschenthaler et al., 2017). These observations 
suggest that the organelle homeostasis function of autophagy 
is important to counteract the secretory burden of this highly 
differentiated cell type and prevent inflammatory sequelae. Also, 
ATGs are generally required to protect the epithelial barrier, po-
tentially through xenophagy or mediating mucus production by 
goblet cells (Benjamin et al., 2013; Conway et al., 2013b; Patel 
et al., 2013). An important role for autophagy in immune cells 
should also be considered. Increased inflammasome activity in 
macrophages and decreased differentiation of antiinflamma-
tory T cells are both consequences of ATG16L1 inhibition, and 
can cause intestinal inflammation (Saitoh et al., 2008; Chu et 
al., 2016; Kabat et al., 2016). However, many of these studies 
rely on animal models in which classic autophagy and related 
processes are difficult to distinguish. ATG16L1T300A disrupts 
secretory autophagy, leading to impaired exocytosis of lyso-
zyme from Paneth cells during Salmonella infection (Bel et al., 
2017), and the effect of ATG16L1T300A on the necroptosis sig-
naling complex likely involves disruption in ATG-mediating im-
mune signaling (Matsuzawa-Ishimoto et al., 2017). In addition 
to being an unstable protein, ATG16L1T300A displays impaired 
binding with TMEM59, a transmembrane protein that mediates 
the trafficking of LC3+ vesicles through a process distinct from 
classic autophagy (Boada-Romero et al., 2016). Also, with the 
exception of graft-versus-host disease (Hubbard-Lucey et al., 
2014), the IBD variant of ATG16L1 is not linked to other inflam-
matory disorders associated with autophagy dysfunction, such 
as Vici syndrome (Lu et al., 2016). Thus, investigating the po-
tential nonautophagic functions of ATG16L1 in maintaining the 
intestinal barrier remains a critically important future direction.
RA is an autoimmune disease that primarily affects the 
joints and is associated with the presence of autoantibodies 
that are reactive to citrullinated peptides that are presented 
by MHC-II molecules. In contrast to IBD, ATG function may 
promote RA. ATG5 is required for generation of citrullinated 
antigens by peptidylarginine deiminases, potentially by mediat-
ing the trafficking of these enzymes to MHC-II antigen loading 
compartments (Ireland and Unanue, 2011). CTLA4 on anti-in-
flammatory T cells binds B7 molecules on dendritic cells to 
inhibit LC3 expression and autophagy, which dampens the ca-
pacity to present antigens (Alissafi et al., 2017). The CTLA4-Ig 
fusion molecule abatacept, which is used to treat RA, also inhib-
its ATG-mediated antigen presentation by dendritic cells, sug-
gesting that dampening autophagy is part of the mechanism of 
action of this drug (Alissafi et al., 2017). Because it is currently 
unclear when autophagy or an autophagy-related process such 
as LAP mediates antigen presentation, an important future di-
rection will be to determine which ATGs are necessary for auto-
antigen presentation, and whether this differs among cell types.
Polymorphisms in a noncoding region of ATG5 is asso-
ciated with SLE, a multiorgan autoimmune disease character-
ized by antinuclear antibodies, indicative of improper immune 
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activation toward cellular contents (Harley et al., 2008). ATG5 
in B cells is required for autoantibody generation in the Lpr and 
Tlr7 transgenic mouse models of SLE (Weindel et al., 2015; 
Arnold et al., 2016), consistent with the role of autophagy in 
supporting the secretory burden and organelle homeostasis 
in differentiated B cells (Conway et al., 2013a; Pengo et al., 
2013; Chen et al., 2014, 2015a). In contrast to this proposed 
role of autophagy in B cells that facilitates SLE pathogenesis, 
the genetic ablation of LAP-specific ATGs in phagocytic cells 
results in inefficient clearance of dead cells and their immuno-
genic contents, leading to a SLE-like disease in mice (Martinez 
et al., 2016). Thus, it is possible that inhibiting autophagy may 
ameliorate, whereas inhibiting LAP may exacerbate disease. 
Developing drugs that can exclusively target classic autophagy 
without effecting autophagy-related processes, or vice versa, 
may be necessary to treat certain disorders.
Concluding remarks
Overall, these studies illustrate the wide array of nonautophagic 
functions mediated by the ATG machinery. These diverse 
functions deepen our understanding of ATGs in enacting cell- 
autonomous and non–cell-autonomous biological functions be-
yond self-eating in both normal and disease states. They also 
broach the importance of revisiting phenotypes and functions, 
both in vitro and in vivo, that to date have been attributed to 
classic autophagy based on the genetic analysis of a single 
individual ATG. Going forward, it will be critical for future 
researchers to keep in mind alternative pathways, not just au-
tophagy, upon discovering new ATG-dependent phenotypes. 
Importantly, in future studies to delineate how autophagy influ-
ences both normal physiology and disease, it will be incumbent 
on researchers to interrogate multiple ATGs controlling distinct 
elements of the autophagy trafficking pathway to definitively 
attribute a role for classic autophagy on cell fate and function. 
In a similar vein, as we develop more precise methods to thera-
peutically target specific autophagy machinery components, the 
role of alternative autophagy-related processes and signaling 
pathways merit thoughtful and rigorous consideration.
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